Search in the Abstract Database

Abstracts Search 2019

P332 Multinational comparisons of practices in overseas travel in Crohn’s disease and ulcerative colitis

K. Greveson*1, C. Inglis2, S. Ben-Horin3, S. Ghaly4, Y. Yunki5, R. Leong5

1Royal Free London NHS Foundation Trust, Centre for Gastroenterology, London, UK, 2The University of Notre Dame, Sydney, Australia, 3Sheba Medical Center,, IBD Service and Gastro-Immunology Laboratory Department of Gastroenterology, Tel-Hashomer,, Israel, 4St Vincents Hospital, Gastroenterology, Sydney, Australia, 5Concord General Repatriation Hospital, Department of Gastroenterology and Liver Services, Sydney, Australia

Background

Travelling overseas with inflammatory bowel disease (IBD) has increases in morbidity, however few studies have examined these risks. The aims of this multinational study were to identify global travel-preparation and travel practices in IBD patients, predicting who will experience barriers when travelling overseas.

Methods

Patients from gastroenterology clinics in Australia, England, and Israel were invited to participate in the study. Surveyed topics included disease type and management, pre-travel advice, use of travel insurance, amount of overseas travel, and flare-ups during travel. Participants who answered questions assessing difficulties travelling overseas were defined as experiencing a barrier. Binary logistic regression was used to examine predictors of experiencing barriers.

Results

Survey respondents (n = 1887) from England (n = 1507), Israel (n = 42) and Australia (n = 338) had a mean age range of 30–49 years, 75.6% female (n = 1657), and 60.2% had Crohn’s disease. Pre-travel advice was obtained mostly from IBD specialists (32.7%) and GPs (27.6%), and pertinent pre-travel advice patients requested related to travel insurance (39.6%), care of IBD during travel (28.4%) and drug infusions and transportation (28%). Vaccination rates pre-travel was only 16%. Multi-variate logistic regression indicate significant predictors of experiencing a barrier during overseas travel were sex (p < 0.05, β = 1.39), appropriate travel preparation (β = 3.96, 95% CI 1.07–1.80), IBD severity (β = 1.35, 95% CI 1.70–9.19), and education (β = 1.57, 95% CI 1.23–2.00).

Conclusion

This study is the first to examine international travel practices in the IBD population with a multi-national cohort. As such the results of this study will help inform current IBD specialists how best to prepare IBD patients for international travel.